Nippon India Pharma Fund vs Mirae Asset Healthcare Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
Mirae Asset Healthcare Fund -Regular Growth
Chart Comparison
Overview
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹8357 Cr | ₹2908 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹500 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 05 Jun 2004 | 02 Jul 2018 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare | BSE Healthcare |
Turn Over | 21% | 15% |
Expense Ratio | 1.82 | 1.92 |
Manager | Sailesh Raj Bhan | Vrijesh Kasera |
ISIN Code | INF204K01968 | INF769K01EA2 |
Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Mirae Asset Healthcare Fund - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
1 Month | -0.21% | 0.44% |
6 Month | 10.3% | 11.93% |
1 Year | -1.03% | -0.51% |
3 Year | 23.87% | 22.66% |
5 Year | 18.01% | 17.75% |
SIP Return Analysis
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
6 Month | 2.85% | 4.41% |
1 Year | 8% | 11.03% |
3 Year | 21.14% | 22.68% |
5 Year | 18.27% | 18.67% |
Rolling Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
1 Year | 17.31% | 21.43% |
3 Year | 20.52% | 19.12% |
5 Year | 20.64% | 23.9% |
Risk Management
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
Standard Deviation | 15.03% | 16.36% |
Sharp | 1.00% | 0.85% |
Beta | 0.91% | 1.00% |
Alpha | 0.32% | -2.28% |
Fund Managers
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
Name | Sailesh Raj Bhan | Vrijesh Kasera |
Total AUM | ₹96086 Cr | ₹12061 Cr |
Funds Managed | 5 | 4 |
Nippon India Pharma Fund-Growth Plan-Growth Option | Mirae Asset Healthcare Fund -Regular Growth |
Market Cap
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
Others | 1.56 | 4.95 |
Large Cap | 34.91 | 32.38 |
Mid Cap | 32.08 | 37.95 |
Small Cap | 31.46 | 24.72 |
Sector Allocation
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
Mirae Asset Healthcare Fund -Regular Growth |
---|---|---|
Others | 0.52 | 0.41 |
Healthcare | 99.48 | 98.27 |
Basic Materials | - | 1.31 |
Top Comparisons
Invesco India - Invesco Pan European Equity Fund of Fund - Regular Plan - Growth Option
3Y Returns20.24%
Axis Global Innovation Fund of Fund - Regular Plan - Growth
3Y Returns23.66%
ITI Balanced Advantage Fund Regular - Growth
3Y Returns12.21%
Baroda BNP Paribas Balanced Advantage Fund-Regular Plan -Growth Option
3Y Returns14.19%
Kotak Corporate Bond Fund- Regular Plan-Growth Option
3Y Returns7.6%
Nippon India Corporate Bond Fund - Growth Plan - Growth Option
3Y Returns7.86%
Aditya Birla Sun Life Banking and Financial Services Fund - Regular Plan - Growth
3Y Returns14.74%
Baroda BNP Paribas Banking and Financial Services Fund - Regular - Growth Option
3Y Returns15.42%